Destiny Pharma (DEST)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 37.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 74.00
  • 52 Week Low: 31.50
  • Currency: UK Pounds
  • Shares Issued: 43.87m
  • Volume: 3,408
  • Market Cap: £16.45m
  • RiskGrade: 240

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
43.21% below the market average43.21% below the market average43.21% below the market average43.21% below the market average43.21% below the market average
42.31% above the sector average42.31% above the sector average42.31% above the sector average42.31% above the sector average42.31% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
49.65% above the market average49.65% above the market average49.65% above the market average49.65% above the market average49.65% above the market average
36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average
Price Chg 3m
2.71% above the market average2.71% above the market average2.71% above the market average2.71% above the market average2.71% above the market average
8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average8.77% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
55.38% above the market average55.38% above the market average55.38% above the market average55.38% above the market average55.38% above the market average
46.43% above the sector average46.43% above the sector average46.43% above the sector average46.43% above the sector average46.43% above the sector average
Momentum 20
51.46% above the market average51.46% above the market average51.46% above the market average51.46% above the market average51.46% above the market average
46.43% above the sector average46.43% above the sector average46.43% above the sector average46.43% above the sector average46.43% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
86.05% below the market average86.05% below the market average86.05% below the market average86.05% below the market average86.05% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
78.2% below the market average78.2% below the market average78.2% below the market average78.2% below the market average78.2% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
36.57% below the market average36.57% below the market average36.57% below the market average36.57% below the market average36.57% below the market average
18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average18.52% below the sector average
Cash
6.39% below the market average6.39% below the market average6.39% below the market average6.39% below the market average6.39% below the market average
1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average1.89% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Destiny Pharma Market Data

Currency UK Pounds
Share Price 37.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 74.00
52 Week Low 31.50
Volume 3,408
Shares Issued 43.87m
Market Cap £16.45m
RiskGrade 240

Destiny Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
20.26% below the market average20.26% below the market average20.26% below the market average20.26% below the market average20.26% below the market average
7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average7.14% above the sector average
Price Trend
53.24% below the market average53.24% below the market average53.24% below the market average53.24% below the market average53.24% below the market average
78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average78.95% below the sector average
Income Not Available
Growth Not Available

Destiny Pharma Dividends

No dividends found

Trades for 01-Jul-2020

Time Volume / Share Price
10:10 200 @ 37.95p
08:02 3,208 @ 38.00p

Destiny Pharma Key Personnel

CEO Neil Clark
Chair Nick Rodgers

Top of Page